 Robert Meguid
Concepts (377)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Postoperative Complications | 50 | 2023 | 2235 | 9.360 |
Why?
| | Esophagectomy | 15 | 2023 | 110 | 4.800 |
Why?
| | Esophageal Neoplasms | 15 | 2023 | 281 | 4.450 |
Why?
| | Surgical Procedures, Operative | 9 | 2021 | 215 | 4.240 |
Why?
| | Surgeons | 7 | 2023 | 243 | 3.510 |
Why?
| | Quality Improvement | 22 | 2023 | 963 | 3.200 |
Why?
| | Risk Assessment | 24 | 2023 | 3057 | 2.880 |
Why?
| | Inpatients | 5 | 2023 | 388 | 2.800 |
Why?
| | Thoracic Surgery | 5 | 2023 | 120 | 2.780 |
Why?
| | Preoperative Care | 6 | 2021 | 332 | 2.410 |
Why?
| | Robotic Surgical Procedures | 6 | 2024 | 89 | 2.230 |
Why?
| | Urinary Tract Infections | 4 | 2022 | 136 | 2.190 |
Why?
| | Electronic Health Records | 7 | 2023 | 829 | 2.110 |
Why?
| | Databases, Factual | 19 | 2023 | 1231 | 2.070 |
Why?
| | Retrospective Studies | 52 | 2023 | 12978 | 1.990 |
Why?
| | Lung Neoplasms | 10 | 2023 | 2220 | 1.970 |
Why?
| | Specialties, Surgical | 3 | 2023 | 76 | 1.790 |
Why?
| | Pneumonectomy | 5 | 2019 | 115 | 1.700 |
Why?
| | Surgical Wound Infection | 6 | 2023 | 251 | 1.690 |
Why?
| | Patient Readmission | 7 | 2023 | 634 | 1.640 |
Why?
| | Risk Factors | 28 | 2023 | 9000 | 1.540 |
Why?
| | Hospital Mortality | 11 | 2022 | 814 | 1.540 |
Why?
| | Emergency Treatment | 2 | 2021 | 110 | 1.410 |
Why?
| | Sepsis | 4 | 2023 | 531 | 1.410 |
Why?
| | Informed Consent | 2 | 2020 | 163 | 1.360 |
Why?
| | Humans | 108 | 2024 | 118974 | 1.330 |
Why?
| | Hospitals | 7 | 2022 | 598 | 1.330 |
Why?
| | Thoracic Surgical Procedures | 4 | 2023 | 64 | 1.280 |
Why?
| | Intensive Care Units | 2 | 2022 | 635 | 1.260 |
Why?
| | Models, Statistical | 4 | 2020 | 636 | 1.240 |
Why?
| | Ambulatory Surgical Procedures | 2 | 2023 | 50 | 1.080 |
Why?
| | Laparoscopy | 4 | 2023 | 417 | 1.050 |
Why?
| | Patient Discharge | 3 | 2020 | 796 | 1.040 |
Why?
| | Lung Transplantation | 7 | 2023 | 263 | 1.010 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 5 | 2023 | 968 | 0.980 |
Why?
| | Shock, Septic | 2 | 2023 | 187 | 0.970 |
Why?
| | Middle Aged | 38 | 2023 | 27617 | 0.960 |
Why?
| | Aged | 32 | 2021 | 19657 | 0.950 |
Why?
| | Metastasectomy | 1 | 2023 | 12 | 0.930 |
Why?
| | Hernia, Hiatal | 1 | 2023 | 34 | 0.920 |
Why?
| | United States | 27 | 2023 | 12555 | 0.910 |
Why?
| | General Surgery | 4 | 2021 | 134 | 0.900 |
Why?
| | Logistic Models | 9 | 2023 | 1901 | 0.870 |
Why?
| | Critical Pathways | 1 | 2022 | 79 | 0.830 |
Why?
| | Carcinoma, Pancreatic Ductal | 2 | 2023 | 210 | 0.830 |
Why?
| | Adult | 32 | 2023 | 31512 | 0.810 |
Why?
| | Length of Stay | 7 | 2023 | 1032 | 0.780 |
Why?
| | Patient Admission | 1 | 2022 | 176 | 0.770 |
Why?
| | Surgery Department, Hospital | 1 | 2020 | 21 | 0.760 |
Why?
| | Thoracic Surgery, Video-Assisted | 2 | 2019 | 41 | 0.740 |
Why?
| | Male | 47 | 2023 | 57801 | 0.740 |
Why?
| | Rectal Prolapse | 1 | 2020 | 18 | 0.730 |
Why?
| | Female | 45 | 2023 | 61565 | 0.720 |
Why?
| | Patient Satisfaction | 2 | 2022 | 610 | 0.710 |
Why?
| | Cohort Studies | 11 | 2023 | 5116 | 0.710 |
Why?
| | Venous Thromboembolism | 1 | 2023 | 234 | 0.700 |
Why?
| | Treatment Outcome | 18 | 2023 | 9342 | 0.700 |
Why?
| | Thoracotomy | 1 | 2019 | 84 | 0.690 |
Why?
| | Outpatients | 1 | 2022 | 325 | 0.670 |
Why?
| | Aftercare | 1 | 2020 | 194 | 0.670 |
Why?
| | Cardiac Surgical Procedures | 1 | 2023 | 461 | 0.660 |
Why?
| | Minimally Invasive Surgical Procedures | 5 | 2023 | 158 | 0.660 |
Why?
| | Thoracoscopy | 2 | 2020 | 58 | 0.650 |
Why?
| | Patient Transfer | 2 | 2019 | 143 | 0.650 |
Why?
| | Hospitals, Teaching | 2 | 2009 | 104 | 0.640 |
Why?
| | Pancreatic Neoplasms | 2 | 2023 | 734 | 0.610 |
Why?
| | Morbidity | 4 | 2023 | 296 | 0.590 |
Why?
| | Preoperative Period | 4 | 2021 | 110 | 0.580 |
Why?
| | Tissue and Organ Procurement | 4 | 2023 | 248 | 0.560 |
Why?
| | Postoperative Care | 2 | 2016 | 237 | 0.540 |
Why?
| | Prognosis | 7 | 2023 | 3443 | 0.530 |
Why?
| | Survival Rate | 9 | 2023 | 1720 | 0.510 |
Why?
| | Data Collection | 1 | 2017 | 658 | 0.500 |
Why?
| | Trachea | 1 | 2016 | 226 | 0.500 |
Why?
| | Intubation, Intratracheal | 1 | 2016 | 226 | 0.490 |
Why?
| | Machine Learning | 4 | 2023 | 331 | 0.480 |
Why?
| | Adenocarcinoma | 3 | 2023 | 812 | 0.470 |
Why?
| | Quality of Life | 2 | 2024 | 2366 | 0.470 |
Why?
| | Ischemic Preconditioning | 2 | 2023 | 29 | 0.460 |
Why?
| | Anastomotic Leak | 3 | 2023 | 29 | 0.440 |
Why?
| | Aortic Aneurysm, Abdominal | 3 | 2011 | 118 | 0.420 |
Why?
| | Patient Reported Outcome Measures | 3 | 2024 | 252 | 0.420 |
Why?
| | Veterans | 1 | 2022 | 1208 | 0.400 |
Why?
| | Aged, 80 and over | 9 | 2023 | 6561 | 0.390 |
Why?
| | Pregnancy Complications | 1 | 2015 | 448 | 0.380 |
Why?
| | Conversion to Open Surgery | 2 | 2020 | 13 | 0.380 |
Why?
| | Pain, Postoperative | 2 | 2023 | 211 | 0.370 |
Why?
| | Thoracic Neoplasms | 2 | 2020 | 34 | 0.370 |
Why?
| | Propensity Score | 3 | 2019 | 242 | 0.350 |
Why?
| | Neoadjuvant Therapy | 2 | 2021 | 333 | 0.350 |
Why?
| | Aneurysm, Ruptured | 1 | 2009 | 38 | 0.340 |
Why?
| | Quality Assurance, Health Care | 3 | 2021 | 325 | 0.320 |
Why?
| | Reoperation | 2 | 2023 | 557 | 0.310 |
Why?
| | Triage | 2 | 2020 | 203 | 0.310 |
Why?
| | Pancreatic Diseases | 1 | 2008 | 63 | 0.310 |
Why?
| | Guideline Adherence | 2 | 2023 | 523 | 0.310 |
Why?
| | Disease-Free Survival | 3 | 2023 | 649 | 0.300 |
Why?
| | Pancreaticoduodenectomy | 1 | 2008 | 128 | 0.290 |
Why?
| | Reproducibility of Results | 3 | 2019 | 2874 | 0.290 |
Why?
| | Chylothorax | 2 | 2017 | 12 | 0.290 |
Why?
| | Diaphragm | 2 | 2023 | 36 | 0.290 |
Why?
| | Pneumonia | 2 | 2023 | 592 | 0.280 |
Why?
| | Pancreatectomy | 1 | 2008 | 165 | 0.280 |
Why?
| | Colonic Neoplasms | 1 | 2008 | 224 | 0.280 |
Why?
| | Quality Indicators, Health Care | 2 | 2020 | 295 | 0.270 |
Why?
| | Postoperative Hemorrhage | 2 | 2023 | 79 | 0.260 |
Why?
| | Feasibility Studies | 2 | 2019 | 749 | 0.260 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 348 | 0.250 |
Why?
| | Coronavirus Infections | 2 | 2020 | 339 | 0.250 |
Why?
| | Magnetic Resonance Imaging | 1 | 2015 | 3174 | 0.240 |
Why?
| | Smoking | 2 | 2012 | 1487 | 0.230 |
Why?
| | Respiratory Paralysis | 1 | 2023 | 3 | 0.230 |
Why?
| | Comorbidity | 3 | 2022 | 1527 | 0.230 |
Why?
| | Time Factors | 6 | 2021 | 6412 | 0.230 |
Why?
| | Herniorrhaphy | 1 | 2023 | 52 | 0.230 |
Why?
| | Algorithms | 3 | 2019 | 1541 | 0.220 |
Why?
| | Fluorouracil | 1 | 2023 | 151 | 0.220 |
Why?
| | Risk Adjustment | 1 | 2023 | 79 | 0.220 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2023 | 900 | 0.220 |
Why?
| | Advisory Committees | 1 | 2023 | 212 | 0.210 |
Why?
| | Colorectal Surgery | 1 | 2022 | 22 | 0.210 |
Why?
| | Tissue Donors | 2 | 2023 | 336 | 0.210 |
Why?
| | Heart Transplantation | 2 | 2023 | 671 | 0.200 |
Why?
| | Focus Groups | 1 | 2023 | 387 | 0.200 |
Why?
| | Neoplasm Staging | 4 | 2020 | 1223 | 0.200 |
Why?
| | Databases as Topic | 1 | 2021 | 73 | 0.200 |
Why?
| | Lung | 2 | 2024 | 3664 | 0.190 |
Why?
| | Fear | 1 | 2023 | 307 | 0.190 |
Why?
| | Arthroplasty | 1 | 2020 | 52 | 0.180 |
Why?
| | Prospective Studies | 4 | 2024 | 6471 | 0.180 |
Why?
| | Betacoronavirus | 2 | 2020 | 254 | 0.180 |
Why?
| | Intermediate Care Facilities | 1 | 2019 | 4 | 0.180 |
Why?
| | Robotics | 1 | 2021 | 83 | 0.180 |
Why?
| | Emergencies | 1 | 2021 | 153 | 0.180 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 1 | 1999 | 34 | 0.180 |
Why?
| | Elective Surgical Procedures | 1 | 2021 | 160 | 0.180 |
Why?
| | Education, Medical, Graduate | 2 | 2017 | 399 | 0.180 |
Why?
| | Benchmarking | 1 | 2021 | 172 | 0.180 |
Why?
| | Societies, Medical | 1 | 2023 | 703 | 0.170 |
Why?
| | Physical Fitness | 1 | 2020 | 179 | 0.170 |
Why?
| | Glutamine | 1 | 1999 | 88 | 0.170 |
Why?
| | Digestive System Surgical Procedures | 1 | 2020 | 91 | 0.170 |
Why?
| | Geography | 1 | 2019 | 190 | 0.170 |
Why?
| | Datasets as Topic | 1 | 2019 | 103 | 0.170 |
Why?
| | Heat-Shock Proteins | 1 | 1999 | 129 | 0.170 |
Why?
| | Overweight | 1 | 2023 | 502 | 0.170 |
Why?
| | United States Department of Veterans Affairs | 1 | 2022 | 555 | 0.170 |
Why?
| | Hospitals, University | 1 | 2018 | 172 | 0.160 |
Why?
| | Internship and Residency | 3 | 2021 | 1001 | 0.160 |
Why?
| | Medical Oncology | 1 | 2020 | 229 | 0.160 |
Why?
| | Skilled Nursing Facilities | 1 | 2019 | 122 | 0.160 |
Why?
| | Qualitative Research | 1 | 2022 | 953 | 0.160 |
Why?
| | Forecasting | 1 | 2019 | 353 | 0.160 |
Why?
| | Eating | 3 | 1995 | 369 | 0.150 |
Why?
| | Altruism | 1 | 2017 | 30 | 0.150 |
Why?
| | Thoracic Wall | 1 | 2017 | 14 | 0.150 |
Why?
| | Clinical Competence | 3 | 2021 | 951 | 0.150 |
Why?
| | Pain Management | 1 | 2020 | 294 | 0.150 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2020 | 233 | 0.150 |
Why?
| | Gastric Outlet Obstruction | 1 | 2017 | 7 | 0.150 |
Why?
| | Self Efficacy | 1 | 2020 | 366 | 0.150 |
Why?
| | Pylorus | 1 | 2017 | 13 | 0.150 |
Why?
| | Continuity of Patient Care | 1 | 2019 | 265 | 0.150 |
Why?
| | Pleural Effusion | 1 | 2017 | 47 | 0.150 |
Why?
| | Parenteral Nutrition | 2 | 1995 | 92 | 0.150 |
Why?
| | Soft Tissue Infections | 1 | 2017 | 30 | 0.150 |
Why?
| | Frailty | 1 | 2019 | 116 | 0.150 |
Why?
| | Medically Underserved Area | 1 | 2017 | 87 | 0.150 |
Why?
| | Models, Theoretical | 1 | 2021 | 556 | 0.140 |
Why?
| | Abscess | 1 | 2017 | 75 | 0.140 |
Why?
| | Home Care Services | 1 | 2019 | 217 | 0.140 |
Why?
| | Neuromuscular Agents | 1 | 2017 | 31 | 0.140 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2019 | 240 | 0.140 |
Why?
| | Botulinum Toxins, Type A | 1 | 2017 | 42 | 0.140 |
Why?
| | Prevalence | 1 | 2022 | 2326 | 0.140 |
Why?
| | Postoperative Period | 4 | 2021 | 309 | 0.140 |
Why?
| | Chyle | 1 | 2015 | 3 | 0.140 |
Why?
| | Nutritional Support | 1 | 2015 | 28 | 0.130 |
Why?
| | Environmental Exposure | 1 | 2019 | 405 | 0.130 |
Why?
| | Health Status | 1 | 2021 | 726 | 0.130 |
Why?
| | Altitude | 1 | 2019 | 422 | 0.130 |
Why?
| | Multivariate Analysis | 1 | 2019 | 1474 | 0.130 |
Why?
| | Osteomyelitis | 1 | 2017 | 110 | 0.130 |
Why?
| | Monitoring, Intraoperative | 1 | 2015 | 43 | 0.130 |
Why?
| | Factor Analysis, Statistical | 1 | 2016 | 270 | 0.130 |
Why?
| | Orthopedics | 1 | 2017 | 132 | 0.130 |
Why?
| | Body Mass Index | 1 | 2023 | 2092 | 0.130 |
Why?
| | Patient-Centered Care | 1 | 2020 | 497 | 0.130 |
Why?
| | Biomedical Research | 1 | 2021 | 612 | 0.130 |
Why?
| | Healthcare Disparities | 1 | 2020 | 496 | 0.130 |
Why?
| | Radiosurgery | 1 | 2018 | 318 | 0.120 |
Why?
| | Hospitalization | 2 | 2021 | 1785 | 0.120 |
Why?
| | Proportional Hazards Models | 3 | 2018 | 1125 | 0.120 |
Why?
| | Colorado | 3 | 2018 | 4196 | 0.120 |
Why?
| | Hospitals, Veterans | 1 | 2015 | 246 | 0.120 |
Why?
| | Hypotension | 1 | 2015 | 120 | 0.120 |
Why?
| | Sensitivity and Specificity | 1 | 2018 | 1795 | 0.120 |
Why?
| | Research Design | 1 | 2020 | 969 | 0.120 |
Why?
| | Age Factors | 1 | 2021 | 2995 | 0.120 |
Why?
| | Proteins | 1 | 1999 | 938 | 0.110 |
Why?
| | Case-Control Studies | 4 | 2022 | 3171 | 0.110 |
Why?
| | Health Services Research | 1 | 2016 | 385 | 0.110 |
Why?
| | Decision Making | 1 | 2020 | 809 | 0.110 |
Why?
| | Stomach | 2 | 2023 | 103 | 0.110 |
Why?
| | Leiomyosarcoma | 1 | 2012 | 23 | 0.110 |
Why?
| | RNA, Messenger | 2 | 1999 | 2657 | 0.110 |
Why?
| | Practice Guidelines as Topic | 1 | 2020 | 1440 | 0.110 |
Why?
| | DNA-Binding Proteins | 1 | 1999 | 1346 | 0.110 |
Why?
| | Heart Neoplasms | 1 | 2012 | 50 | 0.110 |
Why?
| | Arterial Occlusive Diseases | 1 | 2012 | 74 | 0.110 |
Why?
| | Energy Intake | 1 | 1995 | 447 | 0.100 |
Why?
| | Follow-Up Studies | 3 | 2019 | 4596 | 0.100 |
Why?
| | Endoleak | 1 | 2011 | 13 | 0.100 |
Why?
| | Intestinal Fistula | 1 | 2011 | 12 | 0.100 |
Why?
| | Pulmonary Emphysema | 1 | 2015 | 327 | 0.100 |
Why?
| | Duodenal Diseases | 1 | 2011 | 10 | 0.100 |
Why?
| | Practice Patterns, Physicians' | 1 | 2020 | 1200 | 0.100 |
Why?
| | Transcription Factors | 1 | 1999 | 1570 | 0.100 |
Why?
| | Pulmonary Valve | 1 | 2012 | 99 | 0.100 |
Why?
| | Heart Valve Diseases | 1 | 2012 | 135 | 0.100 |
Why?
| | Transplant Recipients | 2 | 2023 | 148 | 0.100 |
Why?
| | Body Composition | 1 | 1995 | 653 | 0.100 |
Why?
| | Adipose Tissue | 1 | 1995 | 606 | 0.100 |
Why?
| | Aortic Diseases | 1 | 2011 | 94 | 0.090 |
Why?
| | Hospitals, District | 1 | 2009 | 4 | 0.090 |
Why?
| | Anastomosis, Surgical | 2 | 2023 | 146 | 0.090 |
Why?
| | Obesity | 1 | 2023 | 2746 | 0.090 |
Why?
| | Pancreas, Exocrine | 1 | 2008 | 8 | 0.090 |
Why?
| | Pandemics | 3 | 2023 | 1355 | 0.080 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 4708 | 0.080 |
Why?
| | Patient Selection | 3 | 2020 | 676 | 0.080 |
Why?
| | Chi-Square Distribution | 1 | 2009 | 525 | 0.080 |
Why?
| | Consensus | 2 | 2020 | 534 | 0.080 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2008 | 237 | 0.080 |
Why?
| | Neoplasm Metastasis | 1 | 2009 | 544 | 0.080 |
Why?
| | SEER Program | 1 | 2008 | 205 | 0.080 |
Why?
| | Lymphatic Metastasis | 1 | 2008 | 307 | 0.080 |
Why?
| | Precancerous Conditions | 1 | 2008 | 160 | 0.070 |
Why?
| | Neoplasm Invasiveness | 1 | 2008 | 462 | 0.070 |
Why?
| | Pulmonary Artery | 1 | 2012 | 1063 | 0.070 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2015 | 1137 | 0.070 |
Why?
| | Cause of Death | 1 | 2008 | 380 | 0.070 |
Why?
| | Hypertension | 1 | 2015 | 1203 | 0.070 |
Why?
| | Vascular Surgical Procedures | 1 | 2009 | 262 | 0.070 |
Why?
| | Evidence-Based Medicine | 1 | 2009 | 693 | 0.070 |
Why?
| | Graft Survival | 2 | 2023 | 504 | 0.060 |
Why?
| | Glypicans | 1 | 2023 | 9 | 0.060 |
Why?
| | Kaplan-Meier Estimate | 2 | 2019 | 842 | 0.060 |
Why?
| | Pregnancy | 1 | 2015 | 5691 | 0.060 |
Why?
| | Triglycerides | 2 | 2015 | 519 | 0.060 |
Why?
| | Odds Ratio | 2 | 2019 | 996 | 0.050 |
Why?
| | Dyspnea | 1 | 2023 | 201 | 0.050 |
Why?
| | Neurosurgical Procedures | 1 | 2023 | 164 | 0.050 |
Why?
| | Adolescent | 3 | 2023 | 18480 | 0.050 |
Why?
| | Colectomy | 1 | 2022 | 84 | 0.050 |
Why?
| | Longitudinal Studies | 1 | 2008 | 2513 | 0.050 |
Why?
| | Fatigue | 1 | 2023 | 297 | 0.050 |
Why?
| | Esophagogastric Junction | 1 | 2021 | 41 | 0.050 |
Why?
| | Induction Chemotherapy | 1 | 2021 | 59 | 0.050 |
Why?
| | Tumor Cells, Cultured | 2 | 1999 | 874 | 0.050 |
Why?
| | Learning Curve | 1 | 2021 | 67 | 0.050 |
Why?
| | Professional Practice Gaps | 1 | 2020 | 10 | 0.050 |
Why?
| | Child | 1 | 2020 | 19129 | 0.050 |
Why?
| | Comparative Effectiveness Research | 1 | 2021 | 132 | 0.050 |
Why?
| | Predictive Value of Tests | 2 | 2019 | 1868 | 0.050 |
Why?
| | Glutaminase | 1 | 1999 | 9 | 0.040 |
Why?
| | Margins of Excision | 1 | 2019 | 31 | 0.040 |
Why?
| | Transcription Factor CHOP | 1 | 1999 | 29 | 0.040 |
Why?
| | Chemoradiotherapy | 1 | 2021 | 200 | 0.040 |
Why?
| | Walk Test | 1 | 2019 | 49 | 0.040 |
Why?
| | Hydrolysis | 1 | 1999 | 176 | 0.040 |
Why?
| | Evidence-Based Practice | 1 | 2021 | 193 | 0.040 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2023 | 671 | 0.040 |
Why?
| | Time-to-Treatment | 1 | 2020 | 149 | 0.040 |
Why?
| | Serum Albumin | 1 | 2019 | 146 | 0.040 |
Why?
| | Confidence Intervals | 2 | 2009 | 324 | 0.040 |
Why?
| | Molecular Chaperones | 1 | 1999 | 174 | 0.040 |
Why?
| | Health Services Needs and Demand | 1 | 2020 | 254 | 0.040 |
Why?
| | Sarcopenia | 1 | 2019 | 72 | 0.040 |
Why?
| | ROC Curve | 1 | 2019 | 473 | 0.040 |
Why?
| | Needs Assessment | 1 | 2020 | 327 | 0.040 |
Why?
| | Alternative Splicing | 1 | 1999 | 193 | 0.040 |
Why?
| | Activities of Daily Living | 1 | 2020 | 354 | 0.040 |
Why?
| | Occupational Health | 1 | 2020 | 172 | 0.040 |
Why?
| | Cell Division | 1 | 1999 | 776 | 0.040 |
Why?
| | Negative-Pressure Wound Therapy | 1 | 2017 | 11 | 0.040 |
Why?
| | HIV Infections | 1 | 2012 | 2459 | 0.040 |
Why?
| | Clinical Decision-Making | 1 | 2020 | 278 | 0.040 |
Why?
| | Clinical Audit | 1 | 2016 | 13 | 0.040 |
Why?
| | Competency-Based Education | 1 | 2017 | 67 | 0.040 |
Why?
| | Education | 1 | 2017 | 105 | 0.040 |
Why?
| | Cell Line | 2 | 1999 | 2707 | 0.040 |
Why?
| | Gastric Emptying | 1 | 2017 | 40 | 0.040 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 1999 | 404 | 0.040 |
Why?
| | Regression Analysis | 1 | 2019 | 983 | 0.040 |
Why?
| | Patient Safety | 1 | 2020 | 281 | 0.040 |
Why?
| | Lymph Nodes | 1 | 2019 | 455 | 0.040 |
Why?
| | Operative Time | 1 | 2016 | 114 | 0.040 |
Why?
| | Cadaver | 1 | 2017 | 327 | 0.040 |
Why?
| | Cell Line, Tumor | 1 | 2023 | 2851 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2023 | 2275 | 0.030 |
Why?
| | Pilot Projects | 1 | 2020 | 1419 | 0.030 |
Why?
| | Electrolytes | 1 | 2015 | 59 | 0.030 |
Why?
| | Infection Control | 1 | 2016 | 135 | 0.030 |
Why?
| | Dietary Fiber | 1 | 2015 | 44 | 0.030 |
Why?
| | Carrier Proteins | 1 | 1999 | 726 | 0.030 |
Why?
| | Micronutrients | 1 | 2015 | 79 | 0.030 |
Why?
| | Blood Pressure Determination | 1 | 2015 | 133 | 0.030 |
Why?
| | Dietary Proteins | 1 | 2015 | 130 | 0.030 |
Why?
| | Fatty Acids, Nonesterified | 1 | 1995 | 167 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2017 | 1166 | 0.030 |
Why?
| | Poverty | 1 | 2017 | 444 | 0.030 |
Why?
| | Glycogen | 1 | 1993 | 59 | 0.030 |
Why?
| | Apoptosis | 1 | 2023 | 2484 | 0.030 |
Why?
| | Rats | 4 | 1995 | 5392 | 0.030 |
Why?
| | Transcription, Genetic | 1 | 1999 | 1323 | 0.030 |
Why?
| | Mortality | 1 | 2015 | 299 | 0.030 |
Why?
| | Dietary Fats | 1 | 2015 | 322 | 0.030 |
Why?
| | Staphylococcus epidermidis | 1 | 1993 | 70 | 0.030 |
Why?
| | Analgesics, Opioid | 1 | 2020 | 794 | 0.030 |
Why?
| | Anesthesia, General | 1 | 1992 | 48 | 0.030 |
Why?
| | Maryland | 1 | 2012 | 36 | 0.030 |
Why?
| | Echocardiography, Transesophageal | 1 | 2012 | 89 | 0.030 |
Why?
| | Pulmonary Diffusing Capacity | 1 | 2012 | 58 | 0.030 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2012 | 146 | 0.030 |
Why?
| | Catheterization, Central Venous | 1 | 1993 | 95 | 0.030 |
Why?
| | Carbon Monoxide | 1 | 2012 | 64 | 0.030 |
Why?
| | Disease Management | 1 | 2015 | 571 | 0.020 |
Why?
| | Peritonitis | 1 | 2011 | 79 | 0.020 |
Why?
| | Chronic Disease | 1 | 2017 | 1636 | 0.020 |
Why?
| | Body Weight | 1 | 1995 | 934 | 0.020 |
Why?
| | Endoscopy, Digestive System | 1 | 2011 | 111 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 1995 | 2478 | 0.020 |
Why?
| | Blood Vessel Prosthesis Implantation | 1 | 2011 | 181 | 0.020 |
Why?
| | Staphylococcal Infections | 1 | 1993 | 346 | 0.020 |
Why?
| | Rats, Inbred F344 | 3 | 1993 | 245 | 0.020 |
Why?
| | California | 1 | 2009 | 382 | 0.020 |
Why?
| | Receptors, Notch | 1 | 2008 | 85 | 0.020 |
Why?
| | Safety | 1 | 2009 | 304 | 0.020 |
Why?
| | Socioeconomic Factors | 1 | 2012 | 1129 | 0.020 |
Why?
| | Wounds and Injuries | 1 | 2015 | 772 | 0.020 |
Why?
| | Breast Neoplasms | 1 | 1999 | 1965 | 0.020 |
Why?
| | Endovascular Procedures | 1 | 2011 | 276 | 0.020 |
Why?
| | Transplantation, Homologous | 1 | 2008 | 415 | 0.020 |
Why?
| | Liver | 1 | 1995 | 1816 | 0.020 |
Why?
| | Academic Medical Centers | 1 | 2008 | 422 | 0.020 |
Why?
| | Cost-Benefit Analysis | 1 | 2008 | 554 | 0.020 |
Why?
| | Animals | 5 | 2008 | 33381 | 0.020 |
Why?
| | Graft Rejection | 1 | 2008 | 555 | 0.020 |
Why?
| | Young Adult | 1 | 2020 | 10793 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2008 | 1158 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2008 | 2025 | 0.010 |
Why?
| | Incidence | 1 | 2008 | 2424 | 0.010 |
Why?
| | Brain | 1 | 1993 | 2490 | 0.010 |
Why?
| | Registries | 1 | 2009 | 1810 | 0.010 |
Why?
| | Blotting, Northern | 1 | 1999 | 194 | 0.010 |
Why?
| | DNA, Complementary | 1 | 1999 | 268 | 0.010 |
Why?
| | Sequence Alignment | 1 | 1999 | 336 | 0.010 |
Why?
| | Sequence Homology, Amino Acid | 1 | 1999 | 372 | 0.010 |
Why?
| | Tissue Distribution | 1 | 1999 | 334 | 0.010 |
Why?
| | Isoenzymes | 1 | 1999 | 297 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 1999 | 546 | 0.010 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 1999 | 290 | 0.010 |
Why?
| | Sequence Analysis, DNA | 1 | 1999 | 755 | 0.010 |
Why?
| | Base Sequence | 1 | 1999 | 2159 | 0.010 |
Why?
| | Signal Transduction | 1 | 2008 | 4709 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 1999 | 2071 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 1999 | 2871 | 0.010 |
Why?
| | Osmolar Concentration | 1 | 1993 | 185 | 0.010 |
Why?
| | Chloral Hydrate | 1 | 1992 | 3 | 0.010 |
Why?
| | Periodicity | 1 | 1992 | 56 | 0.010 |
Why?
| | Leukocyte Count | 1 | 1993 | 305 | 0.010 |
Why?
| | Organ Specificity | 1 | 1993 | 278 | 0.010 |
Why?
| | Mice | 1 | 2008 | 15520 | 0.010 |
Why?
| | Food Preferences | 1 | 1992 | 119 | 0.010 |
Why?
| | Circadian Rhythm | 1 | 1992 | 401 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 1993 | 3730 | 0.000 |
Why?
|
|
Meguid's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|